163 related articles for article (PubMed ID: 29893311)
21. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study.
Khosravi Shadmani F; Ayubi E; Khazaei S; Sani M; Mansouri Hanis S; Khazaei S; Soheylizad M; Mansori K
Epidemiol Health; 2017; 39():e2017020. PubMed ID: 28774167
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and trend of common cancers in Iran (2004-2008).
Amori N; Aghajani M; Asgarian FS; Jazayeri M
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26811194
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology Characteristics and Trends of Lung Cancer Incidence in Iran.
Almasi Z; Salehiniya H; Amoori N; Enayatrad M
Asian Pac J Cancer Prev; 2016; 17(2):557-62. PubMed ID: 26925643
[TBL] [Abstract][Full Text] [Related]
24. Thyroid Cancer Epidemiology in Iran: a Time Trend Study.
Safavi A; Azizi F; Jafari R; Chaibakhsh S; Safavi AA
Asian Pac J Cancer Prev; 2016; 17(1):407-12. PubMed ID: 26838247
[TBL] [Abstract][Full Text] [Related]
25. Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease.
Zhang Y; Zhu C; Curado MP; Zheng T; Boyle P
BJU Int; 2012 Jan; 109(1):52-6. PubMed ID: 21592300
[TBL] [Abstract][Full Text] [Related]
26. Association Between Human Papillomavirus and Transitional Cell Carcinoma of the Bladder.
Abdollahzadeh P; Madani SH; Khazaei S; Sajadimajd S; Izadi B; Najafi F
Urol J; 2017 Nov; 14(6):5047-5050. PubMed ID: 29101759
[TBL] [Abstract][Full Text] [Related]
27. Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
Masoompour SM; Lankarani KB; Honarvar B; Tabatabaee SH; Moghadami M; Khosravizadegan Z
PLoS One; 2016; 11(5):e0155669. PubMed ID: 27219458
[TBL] [Abstract][Full Text] [Related]
28. Incidence of cancers in Kuzestan province of iran: trend from 2004 to 2008.
Amoori N; Mirzaei M; Cheraghi M
Asian Pac J Cancer Prev; 2014; 15(19):8345-9. PubMed ID: 25339027
[TBL] [Abstract][Full Text] [Related]
29. Primary Liver Cancer in Golestan Province, Northeastern Iran: 13-Year Experience of Golestan Population-Based Cancer Registry (GPCR).
Isapanah Amlashi F; Ashkbari A; Amiriani T; Norouzi A; Poorkhani AH; Sedaghat SM; Livani S; Ashaari M; Sadeghzadeh H; Besharat S; Semnani S; Roshandel G
Arch Iran Med; 2021 Oct; 24(10):727-732. PubMed ID: 34816693
[TBL] [Abstract][Full Text] [Related]
30. Time Trend Analysis of Cancer Incidence in Caspian Sea, 2004 - 2009: A Population-based Cancer Registries Study (northern Iran).
Salehiniya H; Ghobadi Dashdebi S; Rafiemanesh H; Mohammadian-Hafshejani A; Enayatrad M
Caspian J Intern Med; 2016; 7(1):25-30. PubMed ID: 26958329
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and Trend of Head and Neck Cancers in Iran.
Mirzaei M; Hosseini SA; Ghoncheh M; Soheilipour F; Soltani S; Soheilipour F; Salehiniya H
Glob J Health Sci; 2015 May; 8(1):189-93. PubMed ID: 26234980
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer in Iran: Epidemiology and morphology trends.
Rafiemanesh H; Pakzad R; Abedi M; Kor Y; Moludi J; Towhidi F; Reza Makhsosi B; Salehiniya H
EXCLI J; 2016; 15():738-744. PubMed ID: 28337105
[TBL] [Abstract][Full Text] [Related]
33. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, northern Iran.
Ahmadi M; Ranjbaran H; Amiri MM; Nozari J; Mirzajani MR; Azadbakht M; Hosseinimehr SJ
Asian Pac J Cancer Prev; 2012; 13(10):5053-6. PubMed ID: 23244109
[TBL] [Abstract][Full Text] [Related]
34. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran.
Basiri A; Shakhssalim N; Jalaly NY; Miri HH; Partovipour E; Panahi MH
Asian Pac J Cancer Prev; 2014; 15(3):1459-63. PubMed ID: 24606483
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran.
Almasi Z; Rafiemanesh H; Salehiniya H
Asian Pac J Cancer Prev; 2015; 16(7):2757-61. PubMed ID: 25854359
[TBL] [Abstract][Full Text] [Related]
36. Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis.
Liu X; Jiang J; Yu C; Wang Y; Sun Y; Tang J; Chen T; Bi Y; Liu Y; Zhang ZJ
Cancer Epidemiol; 2019 Aug; 61():95-103. PubMed ID: 31176961
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009.
Vakili M; Pirdehghan A; Adimi M; Sadeghian M; Akhondi M
J Res Health Sci; 2014; 14(3):210-3. PubMed ID: 25209908
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and Histopathology of Nasopharyngeal Neoplasms in Iran.
Safavi Naini A; Rostami MM; Shojaeian F; Azizmohammad Looha M; Ghanbari Motlagh A; Safavi AA; Safavi-Naini SAA
Iran J Otorhinolaryngol; 2023 Jan; 35(126):3-12. PubMed ID: 36721417
[TBL] [Abstract][Full Text] [Related]
39. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.
Andreassen BK; Aagnes B; Gislefoss R; Andreassen M; Wahlqvist R
BMC Cancer; 2016 Oct; 16(1):799. PubMed ID: 27737647
[TBL] [Abstract][Full Text] [Related]
40. A joinpoint and age-period-cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016.
Abolhosseini M; Khorrami Z; Safi S; Akbari ME; Moshtaghion SM; Mohammadi SF; Kanavi MR; Karimi S
Sci Rep; 2023 Jan; 13(1):1074. PubMed ID: 36658192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
